Related references
Note: Only part of the references are listed.1H NMR-based dynamic metabolomics delineates the therapeutic effects of Baoyuan decoction on isoproterenol-induced cardiac hypertrophy
Zhiyong Du et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
The Drug Candidate BGP-15 Delays the Onset of Diastolic Dysfunction in the Goto-Kakizaki Rat Model of Diabetic Cardiomyopathy
Mariann Bombicz et al.
MOLECULES (2019)
Effects of exercise preconditioning and HSP72 on diaphragm muscle function during mechanical ventilation
Ashley J. Smuder et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Resting Heart Rate Variability Predicts Vulnerability to Pharmacologically-Induced Ventricular Arrhythmias in Male Rats
Luca Carnevali et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Curcumin Nanoparticles Protect against Isoproterenol Induced Myocardial Infarction by Alleviating Myocardial Tissue Oxidative Stress, Electrocardiogram, and Biological Changes
Paul-Mihai Boarescu et al.
MOLECULES (2019)
Quantification of Bisoprolol and Metoprolol in Simultaneous Human Serum and Cerebrospinal Fluid Samples
Ali Sigaroudi et al.
PHARMACOLOGY (2018)
Heart Disease and Stroke Statistics-2018 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2018)
Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis
Sara Gandini et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Heat Shock Proteins and Autophagy Pathways in Neuroprotection: From Molecular Bases to Pharmacological Interventions
Botond Penke et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Loop diuretics are associated with greater risk of sarcopenia in patients with non-dialysis-dependent chronic kidney disease
Seiko Ishikawa et al.
PLOS ONE (2018)
Impaired PARP activity in response to the β-adrenergic receptor agonist isoproterenol
Mara Thomas et al.
TOXICOLOGY IN VITRO (2018)
Exogenous Hydrogen Sulfide Supplement Attenuates Isoproterenol-Induced Myocardial Hypertrophy in a Sirtuin 3-Dependent Manner
Jingyao Zhang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Antihypertensive drugs
Stephane Laurent
PHARMACOLOGICAL RESEARCH (2017)
Insulin and β Adrenergic Receptor Signaling: Crosstalk in Heart
Qin Fu et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
β-Adrenergic Receptor and Insulin Resistance in the Heart
Supachoke Mangmool et al.
BIOMOLECULES & THERAPEUTICS (2017)
Chaperone co-inducer BGP-15 inhibits histone deacetylases and enhances the heat shock response through increased chromatin accessibility
Marek A. Budzyanski et al.
CELL STRESS & CHAPERONES (2017)
Differential Metabolic Effects of Beta-Blockers: an Updated Systematic Review of Nebivolol
Maria Marketou et al.
CURRENT HYPERTENSION REPORTS (2017)
BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle
Tahnee L. Kennedy et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Hsp70 plays an important role in high-fat diet induced gestational hyperglycemia in mice
Baoheng Xing et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2015)
Activating HSP72 in Rodent Skeletal Muscle Increases Mitochondrial Number and Oxidative Capacity and Decreases Insulin Resistance
Darren C. Henstridge et al.
DIABETES (2014)
Improvement of Insulin Sensitivity by a Novel Drug Candidate, BGP-15, in Different Animal Studies
Botond Literati-Nagy et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2014)
The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice
Geeta Sapra et al.
NATURE COMMUNICATIONS (2014)
On ceramides, other sphingolipids and impaired glucose homeostasis
Philip J. Larsen et al.
MOLECULAR METABOLISM (2014)
Hydroximic Acid Derivatives: Pleiotropic Hsp Co-Inducers Restoring Homeostasis and Robustness
Tim Crul et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Synergetic Insulin Sensitizing Effect of Rimonabant and BGP-15 in Zucker-Obes Rats
Zsuzsanna Literati-Nagy et al.
PATHOLOGY & ONCOLOGY RESEARCH (2013)
The HSP co-inducer BGP-15 can prevent the metabolic side effects of the atypical antipsychotics
Zsuzsanna Literati-Nagy et al.
CELL STRESS & CHAPERONES (2012)
Hsp72 preserves muscle function and slows progression of severe muscular dystrophy
Stefan M. Gehrig et al.
NATURE (2012)
A Novel Insulin Sensitizer Drug Candidate-BGP-15-Can Prevent Metabolic Side Effects of Atypical Antipsychotics
Zsuzsanna Literati-Nagy et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Effects of different small HSPB members on contractile dysfunction and structural changes in a Drosophila melanogaster model for Atrial Fibrillation
Deli Zhang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Membrane-Lipid Therapy in Operation: The HSP Co-Inducer BGP-15 Activates Stress Signal Transduction Pathways by Remodeling Plasma Membrane Rafts
Imre Gombos et al.
PLOS ONE (2011)
Beneficial effect of the insulin sensitizer (HSP inducer) BGP-15 on olanzapine-induced metabolic disorders
B. Literati-Nagy et al.
BRAIN RESEARCH BULLETIN (2010)
Improvement of Insulin Sensitivity by a Novel Drug, BGP-15, in Insulin-resistant Patients: A Proof of Concept Randomized Double-blind Clinical Trial
B. Literati-Nagy et al.
HORMONE AND METABOLIC RESEARCH (2009)
HSP72 protects against obesity-induced insulin resistance
Jason Chung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Can the stress protein response be controlled by 'membrane-lipid therapy'?
Laszlo Vigh et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
Enhanced insulin sensitivity in mice lacking ganglioside GM3
T Yamashita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
BGP-15 - a novel poly(ADP-ribose) polymerase inhibitor - protects against nephrotoxicity of cisplatin without compromising its antitumor activity
I Racz et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system
R Halmosi et al.
MOLECULAR PHARMACOLOGY (2001)
BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase
E Szabados et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
